Mission Ensure the future benefit of cell and gene therapy to everyone in need through reduction of drug manufacturing cost and increased patient accessibility.
Description ThermoGenesis Holdings, Inc. (Nasdaq:THMO), formerly known as Cesca Therapeutics Inc., is a pioneer and market leader in the development and commercialization of automated cell processing technologies for the cell and gene therapy field. ThermoGenesis Corp., a subsidiary of ThermoGenesis Holdings, Inc., markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and large scale cell processing and manufacturing for the emerging CAR-T immunotherapy market.
ThermoGenesis has an employee rating of 2.8 out of 5 stars, based on 20 company reviews on Glassdoor which indicates that most employees have an average working experience there. The ThermoGenesis employee rating is in line with the average (within 1 standard deviation) for employers within the Manufacturing industry (3.5 stars).
Overall, 43% of employees would recommend working at ThermoGenesis to a friend. This is based on 20 anonymously submitted reviews on Glassdoor.
50% of job seekers rate their interview experience at ThermoGenesis as positive. Candidates give an average difficulty score of 3.5 out of 5 (where 5 is the highest level of difficulty) for their job interview at ThermoGenesis.